Thyrocare Appoints Dr Ramesh Kinha as Chief Operating Officer

Thyrocare Technologies Limited (NSE: THYROCARE, BSE: 539871), a leading healthcare diagnostics company, has announced the appointment of Dr Ramesh Kinha as Chief Operating Officer (COO). With this move, Thyrocare continues to strengthen its leadership team as it scales operations across India.

Strengthening Operations and Quality Standards

In his new role, Dr Kinha will lead laboratory operations and further enhance quality standards across Thyrocare’s extensive diagnostic network. Moreover, he will focus on consistently improving diagnostic accuracy and service delivery, thereby reinforcing the company’s commitment to excellence.

Dr Kinha brings over 17 years of experience in the healthcare and diagnostics sector, with deep expertise in laboratory operations and quality systems. His appointment comes at a crucial phase of Thyrocare’s growth, as the company expands its reach nationwide.

Extensive Leadership Experience in Diagnostics

Before joining Thyrocare, Dr Kinha served as Group Director – Laboratory Services at Vijaya Diagnostic Centre Limited, where he successfully led several critical operational and quality initiatives. In addition, his career spans senior leadership roles at Apollo Health & Lifestyle Ltd, Medall Healthcare, Metropolis Healthcare, and SRL Ltd, where he consistently delivered operational excellence and drove strategic transformation.

Also Read |  India Prepares 13 New Quarantine Centres at International Entry Points

As per the press release, Thyrocare expects Dr Kinha’s experience to play a key role in strengthening its laboratory network and operational backbone.

Leadership Perspective

Commenting on his appointment, Dr Ramesh Kinha, Chief Operating Officer of Thyrocare, said,

“Thyrocare has always been a pioneer in making healthcare accessible while striving for excellence. I am excited to optimise our operations, strengthen our quality frameworks, and drive initiatives that will help us deliver affordable, world-class diagnostic services to every Indian.”

Strong Academic and Regulatory Credentials

Dr Kinha holds an MBBS degree and an MD in Pathology. Furthermore, he has completed senior management and leadership programmes at IIM Nagpur and the Indian School of Business (ISB). As a certified NABL assessor, he brings strong expertise in quality assurance and regulatory compliance.

Management Endorsement and Vision Ahead

Sharing his views, Rahul Guha, Managing Director and CEO of API Holdings, stated,

“As Thyrocare continues to scale, strengthening our leadership team remains critical. Dr Kinha’s deep operational and quality expertise, combined with his experience in building high-performance laboratory networks, will significantly support our vision of making quality diagnostics accessible to every Indian.”

Also Read |  AIG Hospitals to Present Real-World AI Use Cases at India AI Impact Summit 2026